is jardiance a glp-1 Ozempic vs Ozempic vs. Jardiance: Key differences

Exp Clin Endocrinol Amp Diabetes (2022) 130:35867

The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade

doi: 10.5483/BMBRep.2020.53.1.279 [DOI] [PMC free article] [PubMed] [Google Scholar] 72

Grns Nutrition, Lemme, and Supergut did not respond to requests for comment

Also known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication is similar to existing weight loss medications like tirzepatide and semaglutide but has increased efficacy

Thats why Ive broken down the latest research , especially from the InfantRisk Center (the leading authority on medication safety while breastfeeding), and created a balanced look at the pros and cons